NSE · OAL · Chemicals
Oriental Aromatics Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹314 Cr with net profit ₹10 Cr — a 3.26% net margin, versus 3.17% the period before.
Shareholding
As of 2026-09-30
- Promoter74.17%
- Public25.83%
- FII0%
- DII0%
22,148 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.83× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #55 of 161 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,74,990 Cr | 77.31 | 22.63 | 29.5% | 17.7% |
| Pidilite Industries Ltd. | ₹1,55,399 Cr | 57.9 | 13.88 | 23.94% | 16.63% |
| SRF Ltd. | ₹73,365 Cr | 31.06 | 4.79 | 14.92% | 12.76% |
| Linde India Limited | ₹58,424 Cr | 118.21 | 13.31 | 11.26% | 18.08% |
| Gujarat Fluorochemicals Ltd. | ₹51,762 Cr | 75.93 | 6.17 | 7.97% | 11.43% |
| Navin Fluorine International Ltd. | ₹51,325 Cr | 56.02 | 11.53 | 20.41% | 22.4% |
| Godrej Industries Ltd. | ₹37,631 Cr | 30.76 | 3.38 | 12.38% | 5.85% |
| Himadri Speciality Chem Limited | ₹28,241 Cr | 33.04 | 5.5 | 16.65% | 15.28% |
| Aether Industries Limited | ₹22,263 Cr | 88.32 | 8.58 | 9.61% | 19.21% |
| Deepak Nitrite Ltd. | ₹21,747 Cr | 20.3 | 3.36 | 16.4% | 10.9% |
| Oriental Aromatics Ltd.(this company) | ₹1,596 Cr | 153.99 | 2.38 | 1.55% | 0.93% |
AI analysis
AI-generated · google/gemini-2.5-flashOriental Aromatics Ltd. operates with a market capitalization of Rs 1181 Cr. The company reported annual revenue of Rs 931.53 Cr with an 11% growth. Its profit margin stands at 32.1%, and diluted EPS is Rs 0.98. The 52-week high for the share price was Rs 421.3 and the 52-week low was Rs 228.
Positives
- +Promoter shareholding is high at 74.17% as of March 31, 2026, indicating confidence from the promoters.
- +The debt-to-equity ratio is 0.43, suggesting a manageable level of debt.
- +The company's profit margin is 32.1%, indicating efficient operations.
- +The Return on Equity (ROE) is 49.8%, indicating effective utilization of shareholders' funds.
Negatives
- −The Return on Capital Employed (ROCE) is relatively low at 4.36%.
- −Net profit in December 2025 was negative at -Rs 1.92 Cr.
- −The diluted EPS is low at Rs 0.98.
Financial performance
Oriental Aromatics Ltd. reported an annual revenue of Rs 931.53 Cr, demonstrating an 11% growth. The annual net profit stands at Rs 33.47 Cr (derived from profit margin * revenue). The company's EPS is Rs 0.98. Quarterly revenue for the period ending March 2026 was Rs 282.37 Cr, with a net profit of Rs 3.99 Cr. The company experienced a brief period of negative net profit in December 2025 at -Rs 1.92 Cr.
Profitability & returns
The company's profit margin is 32.1%. Return on equity (ROE) is 49.8%. The Return on Capital Employed (ROCE) is 4.36%. Looking at recent quarterly data, the net profit for March 2026 was Rs 3.99 Cr, improving from a negative net profit of Rs -1.92 Cr in December 2025.
Balance sheet
Oriental Aromatics Ltd. has a book value of Rs 197.46 per share. The debt-to-equity ratio is 0.43, indicating a moderate level of leverage. No information on total debt or total assets was provided.
Ownership & pledges
Public shareholding is 25.83%. There are no pledged promoter shares.
Regulatory & surveillance
Oriental Aromatics Ltd. is not currently under any surveillance measure.
Data as of — price: 2026-11-14 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.